Crucially, ex vivo pharmacological inhibition of ABHD11 suppressed T cell function in two autoimmune patient cohorts, whilst also attenuating disease activity in a murine model of autoimmunity in vivo. This evidence concerns the gene ABHD11 and Autoimmunity.